113 related articles for article (PubMed ID: 18769787)
1. [Gene methylation patterns in digestive tumors].
Roa S JC; García M P; Melo A A; Tapia E O; Villaseca H M; Araya O JC; Guzmán G P
Rev Med Chil; 2008 Apr; 136(4):451-8. PubMed ID: 18769787
[TBL] [Abstract][Full Text] [Related]
2. Promoter methylation profile in gallbladder cancer.
Roa JC; Anabalón L; Roa I; Melo A; Araya JC; Tapia O; de Aretxabala X; Muñoz S; Schneider B
J Gastroenterol; 2006 Mar; 41(3):269-75. PubMed ID: 16699861
[TBL] [Abstract][Full Text] [Related]
3. [Promoter methylation profile in gastric cancer].
Roa JC; Anabalón L; Roa I; Tapia O; Melo A; Villaseca M; Araya JC
Rev Med Chil; 2005 Aug; 133(8):874-80. PubMed ID: 16163424
[TBL] [Abstract][Full Text] [Related]
4. The methylation status and protein expression of CDH1, p16(INK4A), and fragile histidine triad in nonsmall cell lung carcinoma: epigenetic silencing, clinical features, and prognostic significance.
Nakata S; Sugio K; Uramoto H; Oyama T; Hanagiri T; Morita M; Yasumoto K
Cancer; 2006 May; 106(10):2190-9. PubMed ID: 16598757
[TBL] [Abstract][Full Text] [Related]
5. [Promoter methylation profile in breast cancer].
Roa JC; Anabalón L; Tapia O; Martínez J; Araya JC; Villaseca M; Guzmán P; Roa I
Rev Med Chil; 2004 Sep; 132(9):1069-77. PubMed ID: 15543763
[TBL] [Abstract][Full Text] [Related]
6. Aberrant DNA methylation in non-neoplastic gastric mucosa of H. Pylori infected patients and effect of eradication.
Perri F; Cotugno R; Piepoli A; Merla A; Quitadamo M; Gentile A; Pilotto A; Annese V; Andriulli A
Am J Gastroenterol; 2007 Jul; 102(7):1361-71. PubMed ID: 17509026
[TBL] [Abstract][Full Text] [Related]
7. Promoter hypermethylation of CDH1, FHIT, MTAP and PLAGL1 in gastric adenocarcinoma in individuals from Northern Brazil.
Leal M; Lima E; Silva P; Assumpção P; Calcagno D; Payão S; Burbano RR; Smith M
World J Gastroenterol; 2007 May; 13(18):2568-74. PubMed ID: 17552003
[TBL] [Abstract][Full Text] [Related]
8. [Inactivation of CDKN2A gene (p16) in gallbladder carcinoma].
Roa JC; Vo Q; Araya JC; Villaseca M; Guzmán P; Ibacache GS; de Aretxabala X; Roa I
Rev Med Chil; 2004 Nov; 132(11):1369-76. PubMed ID: 15693199
[TBL] [Abstract][Full Text] [Related]
9. Tumor-specific methylation in bronchial lavage for the early detection of non-small-cell lung cancer.
Kim H; Kwon YM; Kim JS; Lee H; Park JH; Shim YM; Han J; Park J; Kim DH
J Clin Oncol; 2004 Jun; 22(12):2363-70. PubMed ID: 15197197
[TBL] [Abstract][Full Text] [Related]
10. [Hierarchical clustering analysis to detect associations between clinical and pathological features of gastric tumors and hypermethylation of suppressor genes].
Zavala G L; Luengo J V; Ossandón C F; Riquelme S E; Backhouse E C; Palma V M; Argandoña C J; Cumsille MA; Corvalán R A
Rev Med Chil; 2007 Jan; 135(1):17-25. PubMed ID: 17369979
[TBL] [Abstract][Full Text] [Related]
11. Coordinate loss of fragile gene expression in pancreatobiliary cancers: correlations among markers and clinical features.
Bloomston M; Kneile J; Butterfield M; Dillhoff M; Muscarella P; Ellison EC; Melvin WS; Croce CM; Pichiorri F; Huebner K; Frankel WL
Ann Surg Oncol; 2009 Aug; 16(8):2331-8. PubMed ID: 19434452
[TBL] [Abstract][Full Text] [Related]
12. [Gastric carcinoma and chronic gastritis: epigenetic regulation of CDH1 (E-Cadherin), CDKN2A (p16INK4A), PTGS2 (COX-2) and EGFR genes through methylation].
Silva M; Azenha D; Pereira C; Almeida A; Balseiro S; Sampaio AM; Santos P; Carvalho L
Acta Med Port; 2010; 23(1):5-14. PubMed ID: 20353702
[TBL] [Abstract][Full Text] [Related]
13. Aberrant methylation of the FHIT gene in chronic smokers with early stage squamous cell carcinoma of the lung.
Kim JS; Kim H; Shim YM; Han J; Park J; Kim DH
Carcinogenesis; 2004 Nov; 25(11):2165-71. PubMed ID: 15231689
[TBL] [Abstract][Full Text] [Related]
14. Aberrant promoter hypermethylation of multiple genes in gallbladder carcinoma and chronic cholecystitis.
Takahashi T; Shivapurkar N; Riquelme E; Shigematsu H; Reddy J; Suzuki M; Miyajima K; Zhou X; Bekele BN; Gazdar AF; Wistuba II
Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6126-33. PubMed ID: 15447999
[TBL] [Abstract][Full Text] [Related]
15. Hypermethylation of FHIT as a prognostic marker in nonsmall cell lung carcinoma.
Maruyama R; Sugio K; Yoshino I; Maehara Y; Gazdar AF
Cancer; 2004 Apr; 100(7):1472-7. PubMed ID: 15042681
[TBL] [Abstract][Full Text] [Related]
16. A CpG island hypermethylation profile of primary colorectal carcinomas and colon cancer cell lines.
Lind GE; Thorstensen L; Løvig T; Meling GI; Hamelin R; Rognum TO; Esteller M; Lothe RA
Mol Cancer; 2004 Oct; 3():28. PubMed ID: 15476557
[TBL] [Abstract][Full Text] [Related]
17. Promoter hypermethylation of p16INK4a, E-cadherin, O6-MGMT, DAPK and FHIT in adenocarcinomas of the esophagus, esophagogastric junction and proximal stomach.
Schildhaus HU; Kröckel I; Lippert H; Malfertheiner P; Roessner A; Schneider-Stock R
Int J Oncol; 2005 Jun; 26(6):1493-500. PubMed ID: 15870861
[TBL] [Abstract][Full Text] [Related]
18. Characterization of a multiple epigenetic marker panel for lung cancer detection and risk assessment in plasma.
Hsu HS; Chen TP; Hung CH; Wen CK; Lin RK; Lee HC; Wang YC
Cancer; 2007 Nov; 110(9):2019-26. PubMed ID: 17876837
[TBL] [Abstract][Full Text] [Related]
19. Distinct promoter hypermethylation of p16INK4a, CDH1, and RAR-beta in intestinal, diffuse-adherent, and diffuse-scattered type gastric carcinomas.
Oue N; Motoshita J; Yokozaki H; Hayashi K; Tahara E; Taniyama K; Matsusaki K; Yasui W
J Pathol; 2002 Sep; 198(1):55-9. PubMed ID: 12210063
[TBL] [Abstract][Full Text] [Related]
20. Loss of fragile histidine triad gene expression in advanced lung cancer is consequent to allelic loss at 3p14 locus and promoter methylation.
Wali A; Srinivasan R; Shabnam MS; Majumdar S; Joshi K; Behera D
Mol Cancer Res; 2006 Feb; 4(2):93-9. PubMed ID: 16513840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
